ALI EL MENSHAWI: Open Payments
NPI 1568493484 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 30 payments from 8 companies in 2025. Trend: 2023 $1,033 · 2024 $851 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $139 |
| ABBVIE INC. | 5 | $98 |
| Corium, LLC | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: Auvelity, VRAYLAR, Azstarys, REXULTI, COBENFY, CAPLYTA, Relexxii, Jornay PM.
Industry payments across FL — which companies pay providers there.
